Ironwood Pharmaceuticals (NASDAQ: IRWD) revenue
Ironwood Pharmaceuticals reported revenue of $296.2m for fiscal 2025, 15.7% less than in fiscal 2024 ($351.4m). Since fiscal 2016 its revenue has grown by 8.1%, an average growth of 0.9% a year.
Ironwood Pharmaceuticals's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2024, −20.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $296.2m | −15.7% | $98.5m | 33.3% |
| 2024 | $351.4m | −20.6% | $93.1m | 26.5% |
| 2023 | $442.7m | +7.8% | −$945.4m | −213.5% |
| 2022 | $410.6m | −0.8% | $250.3m | 61.0% |
| 2021 | $413.8m | +6.2% | $232.3m | 56.1% |
| 2020 | $389.5m | −9.1% | $142.9m | 36.7% |
| 2019 | $428.4m | +23.6% | $120.1m | 28.0% |
| 2018 | $346.6m | +16.2% | −$150.7m | −43.5% |
| 2017 | $298.3m | +8.9% | −$15.4m | −5.2% |
| 2016 | $274.0m | — | −$51.9m | −18.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Ironwood Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Ironwood Pharmaceuticals ranks 221st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ironwood Pharmaceuticals, −15.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 219th | Healthstream | $304.1m | 4.3% |
| 220th | Evolus | $297.2m | 11.6% |
| 221st | Ironwood Pharmaceuticals | $296.2m | −15.7% |
| 222nd | Rigel Pharmaceuticals | $294.3m | 64.1% |
| 223rd | Xeris Biopharma | $291.8m | 43.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Ironwood Pharmaceuticals
- How much revenue did Ironwood Pharmaceuticals make in fiscal 2025?
- Ironwood Pharmaceuticals reported revenue of $296.2m for fiscal 2025, compared with $351.4m in fiscal 2024.
- How much has the revenue of Ironwood Pharmaceuticals grown?
- Between fiscal 2016 and fiscal 2025 it went from $274.0m to $296.2m: 8.1% more, an average growth of 0.9% a year.
- What was the best year for revenue at Ironwood Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2023, with $442.7m.
- Where does Ironwood Pharmaceuticals rank in its sector by revenue?
- It ranks 221st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Ironwood Pharmaceuticals come from?
- From the annual report (Form 10-K) that Ironwood Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ironwood Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ironwood Pharmaceuticals: the Ironwood Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.